PuSH - Publication Server of Helmholtz Zentrum München

Auner, H.* ; Buckle, M.* ; Deufel, A.* ; Kutateladze, T.* ; Lazarus, L.* ; Mavathur, R.* ; Muskhelishvili, G.* ; Pemberton, I.* ; Schneider, R.* ; Travers, A.*

Mechanism of transcriptional activation by FIS: role of core promoter structure and DNA topology.

J. Mol. Biol. 331, 331-344 (2003)
PMC
Open Access Green as soon as Postprint is submitted to ZB.
The Escherichia coli DNA architectural protein FIS activates transcription from stable RNA promoters on entry into exponential growth and also reduces the level of negative supercoiling. Here we show that such a reduction decreases the activity of the tyrT promoter but that activation by FIS rescues tyrT transcription at non-optimal superhelical densities. Additionally we show that three different "up" mutations in the tyrT core promoter either abolish or reduce the dependence of tyrT transcription on both high negative superhelicity and FIS in vivo and infer that the specific sequence organisation of the core promoter couples the control of transcription initiation by negative superhelicity and FIS. In vitro all the mutations potentiate FIS-independent untwisting of the -10 region while at the wild-type promoter FIS facilitates this step. We propose that this untwisting is a crucial limiting step in the initiation of tyrT RNA synthesis. The tyrT core promoter structure is thus optimised to combine high transcriptional activity with acute sensitivity to at least three major independent regulatory inputs: negative superhelicity, FIS and ppGpp.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2003
HGF-reported in Year 0
ISSN (print) / ISBN 0022-2836
e-ISSN 1089-8638
Quellenangaben Volume: 331, Issue: 2, Pages: 331-344 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502800-001
PubMed ID 12888342
Erfassungsdatum 2003-12-31